title: [Report of two cases of hepatitis B virus reactivation in primary liver carcinoma patients treated with the FOLFOX chemotherapy regimen].
authors.forename: Feng
authors.initials: F
authors.lastname: Wang
authors.forename: Shukui
authors.initials: S
authors.lastname: Qin
authors.forename: Haiqing
authors.initials: H
authors.lastname: Hua
authors.forename: Xiufeng
authors.initials: X
authors.lastname: Liu
authors.forename: Wenshu
authors.initials: W
authors.lastname: Qu
authors.forename: Ping
authors.initials: P
authors.lastname: Li
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D005472:Fluorouracil / Q000009:adverse effects; D006515:Hepatitis B virus / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D002955:Leucovorin / Q000009:adverse effects; D008113:Liver Neoplasms / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009944:Organoplatinum Compounds / Q000009:adverse effects; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D009944:Organoplatinum Compounds; D002955:Leucovorin; D005472:Fluorouracil